Scynexis SCYX
NASDAQ SCYX
$4.91 -0.24 (-4.66%)
At close: Sep 9, 2026 · 4:00 PM EDT

Scynexis (SCYX) Net Shares Issued and Repurchased (2021 - 2026)

Scynexis' (SCYX) quarterly Net Shares Issued and Repurchased came in at $30204.0 in Q1 2026, down 95.5% on a YoY basis from $671925.0 in Q1 2025, and down 96.27% quarter-over-quarter from $809925.0 in Q4 2025.

Analysis

Scynexis (SCYX) Net Shares Issued and Repurchased (2021 - 2026) Analysis & Trends

Scynexis (SCYX) has reported Net Shares Issued and Repurchased for 6 consecutive years, with $30204.0 the latest figure, recorded in Q1 2026.

  • For the quarter ending Q1 2026, Net Shares Issued and Repurchased fell 95.5% year-over-year to $30204.0; the trailing twelve-month figure through Mar 2026 stood at $30204.0 (down 95.5% YoY), and the FY2025 full-year result was $809925.0, down 24.31% from the prior year.
  • Net Shares Issued and Repurchased eased to $30204.0 in Q1 2026 per SCYX's latest filing, from $809925.0 in the prior quarter.
  • Across five years, Net Shares Issued and Repurchased topped out at $1.1 million in Q4 2024 and bottomed at $30204.0 in Q1 2026.
  • Historically, Net Shares Issued and Repurchased has averaged $541686.0 across 5 years, with a median of $671925.0 in 2025.
  • The sharpest annual moves came in 2022 and 2026: Net Shares Issued and Repurchased jumped 344.09% in 2022, then tumbled 95.5% in 2026.
  • Over 5 years, Net Shares Issued and Repurchased stood at $834000.0 in 2022, then slumped by 63.67% to $303000.0 in 2023, then soared by 253.16% to $1.1 million in 2024, then fell by 24.31% to $809925.0 in 2025, then tumbled by 96.27% to $30204.0 in 2026.
  • According to Business Quant data, Net Shares Issued and Repurchased over the past three periods registered $30204.0, $809925.0, and $671925.0 for Q1 2026, Q4 2025, and Q1 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Shares Issued and Repurchased (Qtr)
1 Amgen 211.73 Bn 197.74 Bn 7.24 Bn -
2 Gilead Sciences 180.92 Bn 177.74 Bn 6.22 Bn -
3 Vertex Pharmaceuticals 132.16 Bn 124.30 Bn 2.84 Bn -
4 Regeneron Pharmaceuticals 82.89 Bn 74.90 Bn 3.93 Bn -
5 Argenx Se 61.41 Bn 56.23 Bn 1.37 Bn -
6 Moderna 53.99 Bn 48.85 Bn 52.00 Mn -
7 Alnylam Pharmaceuticals 34.48 Bn 31.18 Bn 992.69 Mn -
8 Biogen 31.15 Bn 29.86 Bn 1.96 Bn -
9 Roivant Sciences 30.05 Bn 30.05 Bn 1.16 Mn -
10 Scynexis 58.41 Mn -56.29 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 30,204.00
Dec 31, 2025 809,925.00
Mar 31, 2025 671,925.00
Dec 31, 2024 1.07 Mn
Mar 31, 2024 862,060.00
Dec 31, 2023 303,000.00
Mar 31, 2023 225,000.00
Dec 31, 2022 834,000.00
Mar 31, 2022 69,000.00
Dec 31, 2021 187,800.00